(1)
Sogulasvhili, T.; Gamkrelidze, N.; Pavliashvili, N.; Kvatchadze, L.; Katsadze, M. Colchicine Plus Rosuvastatin Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities. GBMN 2026, 4 (3), 177-186. https://doi.org/10.52340/GBMN.2026.01.01.180.